Bioasis Technologies Inc. BIOAF
OTC PK
| 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 579.67% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 579.67% | -- | -- | -- | -- |
| Cost of Revenue | -30.01% | -19.45% | -- | -- | -- |
| Gross Profit | 51.85% | 34.00% | -- | -- | -- |
| SG&A Expenses | -5.73% | -8.67% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.13% | -11.92% | -- | -- | -- |
| Operating Income | 19.18% | 16.11% | -- | -- | -- |
| Income Before Tax | 20.38% | -131.21% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.38% | -131.21% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.38% | -131.21% | -- | -- | -- |
| EBIT | 19.18% | 16.11% | -- | -- | -- |
| EBITDA | 20.47% | 16.84% | -- | -- | -- |
| EPS Basic | 24.21% | -148.15% | -- | -- | -- |
| Normalized Basic EPS | 21.30% | -9.90% | -- | -- | -- |
| EPS Diluted | 24.21% | -148.15% | -- | -- | -- |
| Normalized Diluted EPS | 21.30% | -9.90% | -- | -- | -- |
| Average Basic Shares Outstanding | 3.71% | 4.22% | -- | -- | -- |
| Average Diluted Shares Outstanding | 3.71% | 4.22% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |